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ABSTRACT 
We have isolated and sequenced the genes encoding the heat shock proteins 60 
(Hsp60) and 70 (Hsp70) of the salmon pathogen Piscirickettsia salmonis. The sequence 
analysis revealed the expected two open reading frames that encode proteins with 
calculated molecular weights of 60,060 and 70,400. The proteins exhibit a 70-80% 
homology with other known prokaryotic Hsp60 and Hsp70 sequences. The coding 
regions have been expressed in E. coli as thioredoxin fusion proteins. Both 
recombinant proteins were shown to elicit a humoral response when injected 
intraperitoneally in Atlantic salmon and also conferred protection to fish challenged 
with P. salmonis. The present data will facilitate further studies on the involvement of 
heat shock proteins in protective immunity of fish to infection by P. salmonis and their 
potential use in recombinants vaccines against this intracellular pathogen.  
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INTRODUCCION 
The obligate intracellular bacterium Piscirickettsia salmonis is the etiological agent of 
salmonid rickettsial septicemia (SRS), a disease responsible for extensive mortality in 
the Chilean salmon industry (Branson and Nieto, 1991; Fryer et al., 1990; Lannan and 
Fryer, 1993; Fryer and Mauel, 1997). This pathogen has also been identified in the 
Northern hemisphere (House et al., 1999; Brocklebank et al., 1993; Jones et al., 
1998).  
Recently, SRS has been partially controlled through the use of antibiotics, although 
they are not fully effective and have problems derived from their toxicity and 
generation of resistance. Vaccines have proven to work well in preventing infection. 
However, no effective vaccines are currently commercially available against P. 
salmonis. This pathogen grows very slowly in cell lines; it takes 15 to 20 days to 
develop a full cytopathic effect, making it difficult to process large quantities of cells 
and to separate them from host material.  
In our search for potential vaccine candidates we have started the identification and 
study of P. salmonis genes coding for proteins with potential application in the 
production of an effective vaccine to control SRS. In addition to the membrane bound 
transglycosylase and transferrin binding protein (Wilhelm et al., 2004), we have 
directed our efforts toward the P. salmonis heat shock protein genes. It is well known 
that pathogen-derived Hsp are targets used by the host immune response to control 
infection. The Hsp serve as important antigens inducing very strong cellular and 
humoral immune responses (Kaufman, 1990, 1991; Kaufman et al., 1990). Immune 
responses to Hsp have been observed in infectious diseases caused by bacteria, 
protozoa, fungi and nematodes (Zügel and Kaufman, 1999).  
We report here on the isolation, sequencing, and expression of the P. salmonis Hsp60 
(groEL) and Hsp70 (dnaK) genes and the ability of the recombinant proteins in raising 
an antibody response in salmon.  
MATERIAL AND METHODS 
1. Cell cultures.  
Inoculates of the Chinook salmon embryo cell line CHSE-214 (ATCC 1681) maintained 
in liquid nitrogen were thawed, pelleted, resuspended and cultured for 7 days or until 
confluence in 60 ml of complete MEM (Gibco BRL) supplemented with non-essential 
amino acids, glutamine and 5% fetal bovine serum (GIBCO BRL), in T175 flasks at 
16°C.  
2. Bacterial strains and plasmids.  
E. coli strains NovaBlue and BL21 (DE3), used for cloning and expression respectively, 
were obtained from Novagen.  
Inoculates of P. salmonis LF-89 (ATCC VR1361), each containing approximately 1 x 108 
bacteria/ml, were brought to room temperature, added to flasks containing salmon 
cells, and incubated overnight at 16 C. The medium was then replaced by 50 ml of 
fresh complete MEM supplemented with non-essential amino acids, glutamine and FBS 
5% , and cultured for 10-14 days at 16° C. Periodic checks of the degree of cytolysis 
were performed. Cultures were considered ready for harvesting or propagation when 
almost 100% of the cells were cytopathic. Cells adhering to the flask walls were 
scraped, centrifuged twice at 150 xg, and the second supernatant was collected as the 
semi-purified fraction of P. salmonis. Further purification was performed according to 
Miquel et al., (2003).  
The plasmids pET32a (Novagen), pET21a and pGEMT (Promega) were propagated in 
NovaBlue cells in medium Luria Broth (LB) with 100 µg/µl ampicillin at 37°C. E. coli 
BL21(DE3) cells transformed by pET32a or pET21a were grown in LB with 100 µg/ml 
ampicillin.  
3. Cloning of the Hsp60 and Hsp70 coding regions.  
Genomic DNA was extracted from the purified fraction of P. salmonis using Binder's 
procedure (1995) as described previously (Wilhelm et al., 2003). Coding regions of 
Hsp60 and Hsp70 were isolated by PCR amplification using specific primers based on 
information deduced from the sequence of a genomic library obtained in our laboratory 
(Valenzuela et al., unpublished results). The sequence of the primers is shown in Table 
I.  
Amplified products were purified employing the Qiaquick PCR purification kit (Qiagen), 
ligated to pGEMT at 14°C in the presence of T4 DNA ligase and used to transform 
NovaBlue competent cells. Positive clones were selected by blue/white screening using 
lacZ α-complementation.  
TABLE I  
Oligonucleotides used as primers  
 
Primer Sequence 
 
p1  5'-atggagatataagaatg-3'  
p2 5'-ccgcccatgccacccat-3'  
p3 5'-atggctgaaattattggtat-3'  
p4 5'-aacttcttcaaactcagcatc-3'  
p5 
5'-
gacggatccggagatataagaatgtcagca-
3'  
p6 5'-tatgaattcttaaccgcccatgccacccat-
3'  
p7 
5'-
tatgaattcatggctgaaattattggtattg-3'  
p8  
5'-
gtactcgagctaaacttcttcaaactcagcatc-
3'  
 
4. DNA sequencing.  
The Hsp60 and Hsp70 coding sequences were obtained employing Sanger's dideoxy 
procedure (1977) using M13 primers. Products were separated by capillary 
electrophoresis in an ABI 310 Genetic Analyzer (Applied Biosystem Inc.). The P. 
salmonis Hsp60 and Hsp70 coding sequences are registered in the Gene Bank data 
base under accession numbers AY686756 and AY686757 respectively.  
5. Protein production in E. coli.  
The Hsp60 and Hsp70 coding regions previously cloned in pGEM-T were sub-cloned in 
pET32a or pET21a. The plasmids of the recombinant clones were used to transform E. 
coli BL21(DE3) competent cells. Expression of recombinants was induced by incubation 
in LB with 1 mM IPTG. Recombinant proteins were purified by a Ni-agarose column 
(Qiagen). Protein concentration was measured using the Micro BCA kit (Pierce). Protein 
analysis was performed in PAGE-SDS gels according to Laemmli (1970).  
6. Monoclonal antibody production.  
Two-month-old female BALB/c mice were injected intraperitoneally three times at 3-
week intervals with 50 µg of recombinant proteins Hsp60 or Hsp70 diluted in PBS and 
emulsified with Freund adjuvant. Ten days after the final injection, the animals were 
bled from the tail to obtain serum. The humoral response against the recombinant 
proteins was determined by an ELISA according to Jamett et al., (2001). To produce 
hybridoma, spleen cells from the immunized mice with the highest titer against the 
recombinant proteins were isolated and fused with NS0/2 mouse myeloma cells 
according to the general procedure used by Köhler and Milstein (1975) with minor 
modifications as described previously (Jamett et al., 2001).  
7. Immunization of salmon.  
A group of 104 Salmo salar with an average weight of 18 grams were tagged for group 
identification and injected intraperitoneally with 200 µl of an oil-water emulsion 
containing 10 µg of each recombinant Hsp60 and Hsp70. The fish were maintained at 
13°C under controlled conditions of oxygenation, feeding, and water flow in 4 tanks. 
Non-immunized control fish were maintained in the same tanks. Serum from some of 
the treated and control fish was obtained 3 months after vaccination, and the immune 
response against the recombinant proteins was analyzed by ELISA.  
8. Challenge.  
After 625 degree days, a tank containing 13 vaccinated fish, 13 adjuvant injected fish, 
and 13 control non-vaccinated fish was challenged with a dose of P. salmonis 
equivalent to 2XLD50. Mortality of fish was registered periodically and dead fish were 
analyzed to confirm that SRS was the cause of mortality. LD50 was previously 
determined by analyzing cumulative mortality of intraperitonally injected fish with 
serial dilution of P. salmonis. The effectiveness of the vaccine was determined by the 
relative percent survival (RPS), which was calculated as follows: RPS = [1- (% 
mortality of test group ÷ % mortality of control group)] x 100%. 
9. Western blot analysis.  
Recombinant Hsp60 and Hsp70 or whole-cell protein obtained from P. salmonis were 
separated by PAGE-SDS gel electrophoresis, transferred to nitrocellulose (Towbin et 
al., 1979) and analyzed with a dilution of anti-P. salmonis rabbit polyclonal serum, 
specific monoclonal antibodies or with a 1:200 dilution of serum obtained from 
immunized salmon. The blots were developed with an anti-mouse IgG conjugated to 
alkaline phosphatase, or an anti-rabbit IgG conjugated to alkaline phosphatase. 
Incubation with a monoclonal antibody against salmon IgM was included in the analysis 
of salmon serum.  
10. ELISA.  
ELISA assays were carried out according to Aguayo et al. (2002) with minor 
modifications, using recombinant Hsp60 and Hsp70 as antigens and dilutions of serum 
from immunized salmon. Incubation with an anti-salmon IgM monoclonal was included 
before developing the reaction with anti-mouse IgG conjugated to alkaline 
phosphatase.  
  
RESULTS AND DISCUSSION 
1. Isolation of Hsp60 and Hsp70 coding regions of P. salmonis.  
Our laboratory has sequenced approximately 90% of the P. salmonis genome. The 
sequences of the contigs has allowed us to identify about 1,500 genes that are being 
arranged in a circular genome of about 2x106 base pairs. Genes corresponding to heat 
shock proteins Hsp60 and Hsp70 were identified by comparison to sequences of 
genomes of phylogenetically related organisms such as Pseudoalteromonas 
haloplankitis for Hsp60 and Legionella pneumophila for Hsp70. Figure 1 shows that the 
region coding for Hsp60 is found in contigs 291 (1,072 base pairs) and 750 (566 base 
pairs). Contig 291 includes from the 5' end up to nucleotide 1004 and contig 750 
comprises the coding region for the carboxyl end of the protein, from nucleotide 1070 
to nucleotide 1,636.  
 Figure 1. Isolation of the P. salmonis Hsp60 coding region by PCR from 
genomic P. salmonis DNA. The DNA MW ladder is a mixture of Hind III- 
digested Lambda DNA and Hae III digested ØX174 DNA. 
  
This was confirmed by amplifying a fragment of 1,651 base pairs (Fig. 1) with primers 
p1 and p2 (Table I). This fragment was cloned into pGEM-T and sequenced. An open 
reading frame of 1,638 base pairs codifies a protein of 546 amino acids (Fig. 2) 
corresponding to a protein of 60,060 daltons. A high degree of homology was found 
when comparing this protein with Hsp60 of other microorganisms (Fig. 2). 
Comparative analysis of Hsp60 of P. salmonis with that of phylogenetically-related 
microorganisms shows that the first  
lacks a sequence of about 5 amino acids in the carboxyl end, due probably to the 
incomplete data available of the genomic library.  
 Figure 2. Protein sequence comparison of P. salmonis Hsp60 with the 
corresponding proteins from other bacteria. Multi-alignment was 
developed by the Vector NTI Suite 6 program. 
Approximately 70% of the region coding for Hsp70 was found in contigs 2130 (595 
base pairs), 1687 (619 base pairs) and 1748 (581 base pairs) based on an alignment 
with Legionella pneumophila (Fig. 3). The Hsp70 gene was amplified using specific 
primers designed based on the 5' and 3' end sequences of the gene. Primer p3 (Table 
I) contains the sequence of the first 20 nucleotides of the gene found in contig 2130. 
The 3' end was not found in the genomic sequence; as a consequence, primer p4 
(Table I) was designed using a consensus sequence based on a highly conserved 
domain in phylogenetically-related species (see Fig. 4). PCR amplification resulted in a 
fragment of 1920 base pairs, which corresponds to the size of this gene in other 
microorganisms (Fig. 3). The sequence of the 1920 base pairs fragment codifies a 
70,400 dalton protein of 640 amino acids (Fig. 4). The protein shows a high degree of 
homology with Hsp70 of other microorganisms.  
 
Figure 3. Isolation of the P. salmonis Hsp70 coding region by PCR from 
genomic P. salmonis DNA. The DNA MW ladder is a mixture of Hind III 
digested Lambda DNA and Hae III digested ØX174 DNA. 
  
 
Figure 4. Protein sequence comparison of P. salmonis Hsp70 with the 
corresponding proteins from other bacteria. Multi-alignment was 
developed by the Vector NTI Suite 6 program.  
2. Synthesis and characterization of P. salmonis Hsp60 and Hsp70.  
In order to characterize Hsp60 and Hsp70 from P. salmonis and study their 
immunogenic properties we proceeded to express in E. coli the corresponding 
recombinant proteins using vector pET32a, in which the cloned genes are expressed as 
a fusion protein with E. coli thioredoxin. For this purpose, the Hsp60 coding region was 
amplified with primers complementary to the ends of the gene (primers 5 and 6 in 
Table I) containing the restriction sites BamHI and EcoRI. Primer p6 also contained an 
extra nucleotide to complete the glycine codon inferred from the consensus sequence 
for Hsp60 (Fig. 2) and a stop codon. The amplified fragment that codifies an Hsp60 
protein 5 amino acids shorter at the carboxyl end in comparison with its homologue in 
phylogenetically-related species (Fig. 2) was cloned into pGEM-T and digested with 
EcoRI and BamH I. The fragment released was ligated to vector pET32a, which was 
previously digested with the same restriction enzymes. Positive clones were identified 
by enzymatic digestion. BL21(DE3) cells were transformed with the recombinant vector 
pET32a-Hsp60 to express the recombinant protein. After a 3-hour induction the 
recombinant protein was analyzed in a 12.5%PAGE-SDS gel. The protein of the 
expected MW (80 KDa) is found in both, the insoluble and the soluble fractions (Fig. 
5). When necessary, the insoluble fraction was solubilized in 4M urea and the 
recombinant Hsp60 purified in an affinity column with Ni-agarose resin under 
denaturating conditions (Fig. 5).  
The procedure followed for the gene encoding Hsp70 is in essence the same one used 
for Hsp60. The Hsp70 coding region was amplified from the genome of P. salmonis 
with primers 7 and 8 (Table I),complementary to the ends of the gene and containing 
the restriction sites EcoRI and XhoI respectively and a stop codon. The amplified 
fragment was cloned into pGEM-T and later subcloned in pET32a. E. coli BL21 (DE3) 
cells transformed with pET32a-Hsp70 were induced to express the recombinant protein 
for 3 hours, and the recombinant protein was analyzed in a 12.5 PAGE-SDS gel. The 
protein is primarily found in the soluble protein fraction. The recombinant protein was 
purified using a nickel-agarose resin to approximately 85% of purity (Fig. 5).  
 
Figure 5. SDS-PAGE analysis of the expression in E. coli and purification of P. 
salmonis Hsp60 and Hsp70 fusion proteins.  
A: Lane 1 : Molecular weight markers. Lane 2: 10 µg of insoluble protein fraction of 
recombinant BL21(DE3)/ pET32-Hsp60 cells after 3 hours of induction with IPTG. Lane 
3: 10 µg of soluble protein fractions of recombinant BL21(DE3)/pET32-Hsp60 cells 
after 3 hours of induction with IPTG. Lane 4: Purified Trx-Hsp60 recombinant protein 
after Ni-agarosa purification.  
B: Lane 1 : Molecular weight markers. Lane 2: 10 µg of insoluble protein fraction of 
recombinant BL21(DE3)/pET32-Hsp70 cells after 3 hours of induction with IPTG. Lane 
3: 10 µg of soluble protein fraction of recombinant BL21(DE3)/pET32-Hsp70 cells after 
3 hours of induction with IPTG. Lane 4: Purified Trx-Hsp70 recombinant protein after 
Ni-agarosa purification.  
3. Detection of Hsp60 and Hsp70 in P. salmonis cultured in cell lines.  
A good vaccine candidate is expected to be expressed during host infection by the 
pathogen. In an attempt to determine whether the genes coding for Hsp60 and Hsp70 
were expressed during the replication of P. salmonis inside the host cells, CHSE cells 
infected with P. salmonis were cultured until a 90% cytopathic effect was achieved; the 
bacteria was then harvested as described in Methods. Whole-cell P. salmonis protein 
was analyzed by Western blot with monoclonal antibodies produced in mice against the 
recombinant proteins Trx-Hsp60 and Trx-Hsp70. The specificity of the monoclonal 
antibodies for Hsp60 and Hsp70 was previously confirmed by ELISA and Western blot 
against each recombinant protein respectively (data not shown). These antibodies 
recognized the recombinants excised from the thioredoxin fusion peptide with 
enterokinase, confirming their specific interaction with the target. The Western blot in 
Figure 6 shows the presence of Hsp60 and Hsp70 in P. salmonis cultured in the CHSE 
cell line. The detected proteins migrate according to the expected size of the native 
proteins. The mouse antibodies elicited by the recombinant proteins appear specific for 
the P. salmonis heat shock proteins and has no cross reactivity with the eukaryotic 
counterparts since the monoclonal antibodies do not react with proteins of non-infected 
CHSE cells (data not shown).  
 Figure 6. Western blot of Hsp60 and Hsp70 present in P. salmonis.  
Gel was loaded with 30 µg of whole-cell P. salmonis protein and the blotted 
membrane was analyzed with a 1:200 dilution of each monoclonal antibody. 
1: Coomasie blue staining of P. salmonis lysate. 2 and 3: Molecular weight 
markers. 4: Membrane analyzed with a monoclonal antibody against Hsp60. 
5: Membrane analyzed with a monoclonal antibody against Hsp70.  
The high expression of Hsp60 and Hsp70 detected in P. salmonis is coincident with the 
strong production of these proteins described for other intracellular bacteria during infection 
(Fernández et al, 1997). In contrast to their cytoplasmic location in most bacteria and 
eukaryotes, Hsp60 and Hsp70 have been detected in pathogenic bacteria in the periplasm, 
on bacterial surfaces, and sometimes as extracellular secreted proteins during host 
infection (Garduño et al., 1998; Scorpio et al., 1994; Gillis et al., 1985). No leader 
sequences or other recognizable motif that suggest a secretory role are present in the 
chaperonin proteins, raising the possibility of a unique specific transport mechanism for Hsp 
in these pathogens. The surface location of Hsp has been linked to a significant role in 
mediating attachment and invasion of host cells as well as immune modulation activities 
(Ensgraber and Loos, 1992; Huesca et al., 1996; Retzlaff et al., 1994; Hoffman and 
Garduño, 1999).  
   
4. Immunogenic properties of the P. salmonis Hsp60 and Hsp70.  
Immunogenic reactivity of P. salmonis Hsp60 and Hsp70 was studied by the Western 
Blot technique using a polyclonal rabbit serum developed against an extract of P. 
salmonis obtained from a cell culture. Figure 7 shows that both recombinant proteins 
are recognized by the antiserum against P. salmonis. This result confirms that native 
Hsp60 and Hsp70 expressed during the intracellular life cycle of P. salmonis are 
immunogenic in rabbits. We also found that serum from Atlantic salmon that had been 
immunized three months earlier with a formulation containing the two recombinant 
Hsp reacted with the fusion Trx-Hsp60 and Trx-Hsp70. This was analyzed by ELISA 
(Fig. 8) and Western blot (Fig. 9A). To confirm that fish serum recognized epitopes of 
the Hsp and was not merely reacting against the thioredoxin fusion protein, the serum 
was also tested by Western blot against recombinant Hsp60 and Hsp70 not fused to 
thioredoxin obtained by expression with vector pET21a (Fig. 9B and 9C). The 
recognition of both recombinants confirmed that P. salmonis Hsp60 and Hsp70 are 
immunogenic in salmon and thus are bonafide antigens to be included in an 
experimental vaccine to study their ability to protect against P. salmonis infection. 
 
Figure 7. Western blot analysis of recombinant Hsp60 and Hsp70 with 
anti P. salmonis serum.  
A: Trx-Hsp60 tested with a 1:1000 dilution of P. salmonis polyclonal 
serum.  
B: Trx-Hsp70 tested with a 1:1000 dilution of P. salmonis polyclonal 
serum.  
  
 
Figure 8. Measurement of antibodies to Trx-Hsp60 
and Trx-Hsp70 in serum of salmon immunized with 
both recombinant proteins.  
A: ELISA analysis of antibodies against Hsp60 in 
immunized (Ο) and control fish (∆).  
B: ELISA analysis of antibodies against Hsp70 in 
immunized (Ο) and control fish (∆).  
  
 Figure 9. Western blot analysis of serum obtained from salmon 
immunized with recombinant Hsp60 and Hsp70.  
A: Lane 1 : Electrophoretic pattern of a mixture of purified Trx-Hsp60 and 
Trx-Hsp70; Lanes 2-6: blots tested with serum of immunized fish; Lane 7: 
blot tested with serum of non-immunized fish.  
B: Lane 1 : Electrophoretic pattern of whole-cell extract containing 
recombinant T7-Hsp70; Lanes 2-6: blots tested with serum of immunized 
fish; Lane 7: blot tested with serum of non-immunized fish.  
C: Lane 1 : Electrophoretic pattern of whole-cell extract containing 
recombinant T7-Hsp60; Lanes 2-6: blots tested with serum of immunized 
fish; Lane 7: blot tested with serum of non-immunized fish.  
5. Protection against P. salmonis in vaccinated Atlantic salmon.  
One tank containing vaccinated and control non-injected fish was challenged with 
P.salmonis 625 degree days after immunization with the formulation that contained 
recombinant Hsp60 and Hsp70. A group of adjuvantinjected fish was also included in 
the trial as control. At day 21 after P. salmonis infection, control fish started to die and 
cumulative mortality increased dramatically during the next 20 days. In contrast, a 
reduced number of vaccinated fish died during this period, achieving a relative percent 
survival (RPS) of 89.6% at the end of the challenge (Table II). The strong protective 
response elicited by the recombinant formulation contrast with the weak protection 
that has been described for bacterins against P. salmonis (Smith et al., 1997) and is 
coincident with the protective effect elicited by Hsp60 and Hsp70 in other animal 
models (Ferrero et al., 1995; Gómez et al., 1995). In conclusion our data strongly 
supports the use of Hsp60 and Hsp70 as antigens in a recombinant vaccine against the 
intracellular pathogen Piscirickettsia salmonis.  
   
TABLE II  
Protective response of immunized salmon to P. salmonis  
 
  Challenge  
Group   
  30 days 50 days  
  Mortality RPS  Mortality RPS  
 
V1 8%   82.6 8%     89.6 
V0     58%   -26 69% 10.4  
Control   46%    77%   
  
RPS = Relative percent survival  
Control = Non-injected fish  
V0 = Adjuvant-injected fish  
V1 = 
Fish injected with recombinant 
proteins  
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